7 results for author:"Kasper C.K." in Literature citations
Results Customize
› Repeat search in UniProtKB (2)
| Inhibitors of factor VIII in black patients with hemophilia. Viel K.R., Ameri A., Abshire T.C., Iyer R.V., Watts R.G., Lutcher C., Channell C., Cole S.A., Fernstrom K.M., Nakaya S. et al. N. Engl. J. Med. 360:1618-1627(2009) · Mapped (10) |
| Germline mutations in Peruvian patients with hemophilia B: pattern of mutation in Amerindians is similar to the putative endogenous germline pattern. Heit J.A., Thorland E.C., Ketterling R.P., Lind T.J., Daniels T.M., Zapata R.E., Ordonez S.M., Kasper C.K., Sommer S.S. Hum. Mutat. 11:372-376(1998) · UniProtKB (1) |
| Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK haemophilia centre directors organisation Thromb. Haemost. 79:762-766(1998) · UniProtKB (1) |
| Factor IX San Dimas. Substitution of glutamine for Arg-4 in the propeptide leads to incomplete gamma-carboxylation and altered phospholipid binding properties. Ware J., Diuguid D.L., Liebman H.A., Rabiet M.J., Kasper C.K., Furie B.C., Furie B., Stafford D.W. J. Biol. Chem. 264:11401-11406(1989) · UniProtKB (1) · Mapped (1) |
| Functional consequences of an arginine180 to glutamine mutation in factor IX Hilo. Monroe D.M., McCord D.M., Huang M.N., High K.A., Lundblad R.L., Kasper C.K., Roberts H.R. Blood 73:1540-1544(1989) · UniProtKB (1) |
| Use of denaturing gradient gel electrophoresis to detect point mutations in the factor VIII gene. Traystman M.D., Higuchi M., Kasper C.K., Antonarakis S.E., Kazazian H.H. Jr. Genomics 6:293-301(1990) · UniProtKB (1) |
| Characterization of mutations in the factor VIII gene by direct sequencing of amplified genomic DNA. Higuchi M., Wong C., Kochhan L., Olek K., Aronis S., Kasper C.K., Kazazian H.H. Jr., Antonarakis S.E. Genomics 6:65-71(1990) · UniProtKB (1) |